AKT1 and erythema multiforme: In this study, we demonstrated that the synthetic cannabinoid, WIN 55, inhibits hallmark features of EM, such as angiogenesis in HUVECs and proliferation in HESC and 12Z cells by targeting MAPK and Akt signaling cascade.